In agreement with these reports, TH5487 was shown to enhance the sensitivity to the PARP inhibitor Olaparib, in particular in the context of BRCA1 deficiency (Baquero et al., 2022). Here, PARP1 is linked to hyperinsulinemic hypoglycemia, familial, 4.